So the drug lunch today was for Latuda, a new atypical antipsychotic medication. It's about the tenth medication introduced into that family in the last 15 years. As such, they will need some compelling evidence to get any of us to change our prescribing habits, since there's plenty of variety in the previous 9 medications to address most patient's needs.
Damned if they didn't make a compelling case, e.g. the efficacy of some of the more potent medications mixed with the tolerability of some of the milder ones. Of course, they all look nice and shiny when they're new. We'll see how it goes when the rubber hits the road.
P.S. Roast beef sandwich on a kaiser roll; potato salad, and a chocolate chip cookie. Bottle of water.
Drug rep was a dude. Handsome, but not, you know, Julie Bowen or anything.
Sometimes you win, sometimes you lose, sometimes it rains.